Invention Grant
- Patent Title: Multiparticulate crystalline drug compositions having controlled release profiles
- Patent Title (中): 具有控制释放特性的多片晶体药物组合物
-
Application No.: US11004168Application Date: 2004-12-03
-
Publication No.: US07887844B2Publication Date: 2011-02-15
- Inventor: Leah E. Appel , Roderick J. Ray , David K. Lyon , James B. West , Scott B. McCray , Marshall D. Crew , Dwayne T. Friesen , Scott M. Herbig , Julian B. Lo
- Applicant: Leah E. Appel , Roderick J. Ray , David K. Lyon , James B. West , Scott B. McCray , Marshall D. Crew , Dwayne T. Friesen , Scott M. Herbig , Julian B. Lo
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Jennifer A. Kispert; Richard V. Zanzalari
- Main IPC: A61K9/14
- IPC: A61K9/14 ; A61K9/16
Abstract:
A multiparticulate for controlled release of a drug comprises crystalline drug, a glyceride having at least one alkylate substituent of at least 16 carbon atoms, and a poloxamer, wherein at least 70 wt % of the drug in the multiparticulate is crystalline.
Public/Granted literature
- US20050181062A1 Multiparticulate crystalline drug compositions having controlled release profiles Public/Granted day:2005-08-18
Information query
